EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report)’s stock price dropped 25.2% during mid-day trading on Wednesday . The company traded as low as $0.17 and last traded at $0.17. Approximately 5,034 shares changed hands during trading, an increase of 25% from the average daily volume of 4,039 shares. The stock had previously closed at $0.23.
EOM Pharmaceuticals Stock Performance
The stock has a 50-day simple moving average of $0.30 and a 200-day simple moving average of $0.34.
EOM Pharmaceuticals Company Profile
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Featured Articles
- Five stocks we like better than EOM Pharmaceuticals
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Is Enbridge Stock Too Cheap to Pass Up Now?
- With Risk Tolerance, One Size Does Not Fit All
- 5 Best REIT Alternatives for Passive Real Estate Income
- How to Calculate Stock Profit
- 5 Reasons Kroger Should Be On Every Income Investor Watchlist
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
